vimarsana.com
Home
Live Updates
AbCellera Biologics (ABCL) Q1 2023 Earnings Call Transcript : vimarsana.com
AbCellera Biologics (ABCL) Q1 2023 Earnings Call Transcript
ABCL earnings call for the period ending March 31, 2023.
Related Keywords
Canada
,
United States
,
Canadian
,
American
,
Abcellera Biologics
,
Goldman Sachs
,
Steven Mah Cowen
,
Stephen Willey
,
Gaurav Goparaju Berenberg
,
Malcolm Hoffman
,
Evan Seigerman
,
Tryn Stimart
,
Carl Hansen
,
Steven Mah
,
Antonia Borovina
,
Puneet Souda
,
Nishant Gandhi
,
Gaurav Goparaju
,
Nishant Gandhi Truist
,
American Association For Cancer Research
,
Canadian Government Strategic Innovation Fund
,
Government Of Canada Strategic Innovation Fund
,
Teva Pharmaceuticals
,
Company Analyst
,
Steve Willey Stifel Financial Corp
,
Legal Officer
,
Chief Compliance
,
Investor Relations
,
Andrew Booth
,
Motley Fool Stock Advisor
,
Stock Advisor
,
Safe Harbor
,
Private Securities Litigation Reform Act
,
Chief Executive
,
Cancer Research
,
Strategic Innovation Fund
,
Andrea Tan
,
Capital Markets
,
Bloom Burton
,
Stifel Financial
,
Truist Securities
,
Berenberg Capital
,
vimarsana.com © 2020. All Rights Reserved.